How a Patient's Lying Position in Radiotherapy can Affect Survival

by Adeline Dorcas on  April 23, 2018 at 2:13 PM Cancer News
RSS Email Print This Page Comment bookmark
Font : A-A+

The minute difference in the patient's lying position during radiotherapy treatment for lung or oesophageal cancer can be linked to increase survival chances, according to a new study presented at the ESTRO 37 conference.
How a Patient's Lying Position in Radiotherapy can Affect Survival
How a Patient's Lying Position in Radiotherapy can Affect Survival

These differences of only a few millimeters can mean that the radiation treatment designed to target patients' tumors can move fractionally closer to the heart, where it can cause unintentional damage and reduce survival chances.

The finding suggests that survival could be improved by tightening up treatment guidelines to ensure patients are positioned more accurately.

Radiotherapy plays an important role in cancer care in, amongst others, hard to treat tumors such as lung and oesophageal cancer. However, it can cause side-effects, and previous research shows that radiotherapy to the chest can have negative long-term effects on the heart, for example, increasing the risk of heart disease.

When planning radiotherapy treatment, cancer specialists create a CT image of their patient. This reveals the exact position and size of a tumor within the body. At each subsequent treatment, another image is created and used to check that the patient and, therefore, the tumor is in the same position, within a certain threshold, before the treatment is delivered.

The new research was presented by Corinne Johnson, a medical physics Ph.D. student at the Manchester Cancer Research Centre, part of the Christie NHS Foundation Trust and the University of Manchester, UK.

She and her colleagues studied a group of 780 patients with non-small cell lung cancer who were treated with radiotherapy. For each treatment, patients were positioned on the treatment machine, and an image was taken to confirm that they lay within 5mm of their original position. They used the data from these images to gauge how accurately the radiotherapy dose was delivered over the course of treatment, and whether it was shifted slightly closer or slightly further away from the patient's heart.

When they compared these data with how likely patients were to survive, they found that patients with slight shifts towards their hearts were around 30 per cent more likely to die than those with similar sized shifts away from their hearts.

When they repeated the research with a group of 177 oesophageal cancer patients, they found an even greater difference of around 50 per cent. In both groups, the pattern of survival remained even when researchers took other factors such as the patient's age into account.

Johnson explains: "We already know that using imaging can help us to target cancers much more precisely and make radiotherapy treatment more effective."

"This study examines how small differences in how a patient is lying can affect survival, even when an imaging protocol is used. It tells us that even very small remaining errors can have a major impact on patients' survival chances, particularly when tumors are close to a vital organ like the heart."

"By imaging patients more frequently and by reducing the threshold on the accuracy of their position, we can help lower the dose of radiation that reaches the heart and avoid unnecessary damage."

Johnson and her colleagues are now looking at the data in more detail to see whether particular regions of the heart are more sensitive to radiation than others, and they hope to investigate the effect of differences in patient position in other types of cancer.

President of ESTRO, Professor Yolande Lievens, head of the department of radiation oncology at Ghent University Hospital, Belgium, said: "Radiotherapy treatments are given according to strict protocols to ensure that patients get the most effective treatment with the fewest possible side-effects. This research suggests that changes to lung and oesophageal cancer protocols could positively impact the overall survival of patients with these cancers, both of which have relatively high mortality rates."



Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions
Advertisement

Recommended Reading

More News on:

Radiotherapy Hodgkins Lymphoma Non-Hodgkins Lymphoma Amyotrophic Lateral Sclerosis (ALS) Rhabdomyosarcoma Male Breast Cancer External Beam Radiation Therapy for Prostate Cancer Acute Coronary Syndrome Radiosurgery 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive